RESUMO
La quimioterapia oral comenzó a surgir entre 1940 y 1950, se estima que al menos el 25% de los agentes neoplásicos existentes, están previstos para ser orales y de este modo se espera que su administración aumente en los próximos años. El uso de estas drogas oncológicas oral trae ventajas para el paciente como mayor comodidad, participación activa en su tratamiento, menor interferencia con la vida laboral y social y aumento de la calidad de vida. Objetivo: diseñar un programa educativo sobre el autocuidado en el tratamiento de quimioterapia oral en los pacientes adultos oncológicos en su hogar. diseño metodológico: se realizó una búsqueda de diferentes bases de datos como PUBMED, BVS, SCIELO, obteniendo como resultados 104 artículos de los cuales se seleccionan 10 que respondían a la pregunta de investigación. Resultados: tras el análisis de los artículos seleccionados podemos asegurar que educar a los pacientes y sus familias sobre quimioterapia oral, es un gran desafío que necesita de ajustes y mejoras permanentemente. La educación al paciente debe ser constante y permanente[AU]
Oral chemotherapy began to emerge between 1940 and 1950, it is estimated that at least 25% of existing neoplastic agents are expected to be oral and thus its administration is expected to increase in the coming years. The use of these oral cancer drugs brings advantages for the patient such as greater comfort, active participation in their treatment, less interference with work and social life and increased quality of life. Objective: To design an educational program on self-care in the treatment of oral chemotherapy in adult cancer patients at home. Methodological Design: A search of different databases such as Pubmed, BVS, Scielo was carried out, obtaining as results 104 articles of which 10 were selected that responded to the research question. Results: After analyzing the selected articles, we can ensure that educating patients and their families about oral chemotherapy is a great challenge that needs permanent adjustments and improvements. Patient education must be constant and permanent[AU]
A quimioterapia oral começou a surgir entre 1940 e 1950, estima-se que pelo menos 25% dos agentes neoplásicos existentes sejam orais e, portanto, sua administração deverá aumentar nos próximos anos. O uso desses medicamentos para o câncer oral NE | 22Plan educativo a pacientes adultos que reciben citostáticos orales en el hogar / Paola Natalia Oyola / Trabajo recibido: 2 de febrero 2021 · Trabajo aprobado: 29 de abril 2021traz vantagens para o paciente como maior conforto, participação ativa no seu tratamento, menor interferência no trabalho e na vida social e aumento da qualidade de vida. Objetivo: Elaborar um programa educacional sobre autocuidado no tratamento da quimioterapia oral em pacientes adultos com câncer no domicílio. Delineamento metodológico: Foi realizada uma busca em diferentes bases de dados como Pubmed, BVS, Scielo, obtendo-se como resultados 104 artigos dos quais 10 foram selecionados que responderam à questão de pesquisa. Resultados: Após a análise dos artigos selecionados, podemos assegurar que educar os pacientes e seus familiares sobre a quimioterapia oral é um grande desafio que necessita de ajustes e melhorias permanentes. A educação do paciente deve ser constante e permanente[AU]
Assuntos
Humanos , Autocuidado , Educação de Pacientes como Assunto , Tratamento Farmacológico , Citostáticos/administração & dosagem , Citostáticos/uso terapêutico , Cooperação e Adesão ao TratamentoRESUMO
PURPOSE: To determine the current management of oral and intravenous chemotherapy (OC and IVC) in outpatient clinics of Oncology Departments in Spain to detect opportunities for improvement. MATERIALS AND METHODS: The Spanish Society of Medical Oncology designed a questionnaire specifically for Heads of Oncology Department: 142 were invited and 52 responded. RESULTS: In most centers, the waiting time (69.7%) and time at the outpatient clinic (84.8%) was shorter for patients receiving OC compared to those receiving IVC. The time spent at the outpatient clinic by the patients having OC was approximately 30 min (88.5%). In addition, the time expended by the oncologist with each patient was shorter when they were treated with OC in 21.2% of cases. CONCLUSIONS: Patients' waiting times and individual dedication of oncologists might be reduced by administering OC, and general management might be improved. This should be considered when planning therapies if OC is an option.
Assuntos
Instituições de Assistência Ambulatorial/estatística & dados numéricos , Tratamento Farmacológico/estatística & dados numéricos , Oncologia/estatística & dados numéricos , Antineoplásicos/administração & dosagem , Vias de Administração de Medicamentos , Humanos , Oncologia/organização & administração , Oncologistas/estatística & dados numéricos , Espanha , Inquéritos e Questionários , Gerenciamento do TempoRESUMO
As the use of oral chemotherapy continues to rise, new approaches are needed to ensure patient safety. To help address this issue, the American Society of Clinical Oncology/Oncology Nursing Society (ONS) Chemotherapy Administration Safety Standards were expanded in 2013 to include additional measures addressing oral anticancer drugs (OACs). Because minimal data assessing the application of these standards exist, ONS conducted an independent survey of oncology nurses to evaluate the application of these standards in practice as they relate to several areas of OAC use: assessment, consent, patient education, drug verification, and monitoring. The data revealed that, although the standards are followed in many settings, a large number of settings do not have processes in place to support safety standards and ensure patient safety when administering OACs. Information gained in this informal survey can be used to guide additional research and educational initiatives.